EoY 2022-OncoSENS

Week Two of our 2022 End of Year Campaign features MitoSENS (Preventing Damage from Mitochondrial Mutations) – with a disease focus on Challenging Sarcopenia. Also featuring videos from Life Noggin, AMA with Dr. Amit Sharma and Michael Rae.


A TAME Attempt to Slow Aging Part 3: Metastasizing Errors: Human Trials of Metformin to Prevent and Treat Cancer

Metformin has been proposed as an “anti-aging drug,” and scientists are organizing TAME, a major clinical trial to test the idea. In Part 3 of this 5-part series, we look at human trials of metformin in prevention and treatment of cancer.


Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.

© 2024 SENS Research Foundation – ALL RIGHTS RESERVED

Thank you for Subscribing to the SENS Research Foundation Newsletter.

You can also


You can